These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11136367)

  • 1. The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis.
    Rossier P; van Erven S; Wade DT
    Eur J Neurol; 2000 Nov; 7(6):741-4. PubMed ID: 11136367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis.
    Lee BS; Jones J; Lang M; Achey R; Dai L; Lobel DA; Nagel SJ; Machado AG; Bethoux F
    J Neurosurg; 2018 Oct; 129(4):1056-1062. PubMed ID: 29192855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis.
    Hedley DW; Maroun JA; Espir ML
    Postgrad Med J; 1975 Sep; 51(599):615-8. PubMed ID: 1105499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Lioresal in spasticity].
    Castaigne P; Held JP; Laplane D; Pierrot-Deseilligny E; Bussel B; Macquart-Moulin J
    Rev Neurol (Paris); 1973 Apr; 128(4):245-50. PubMed ID: 4774911
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study.
    Basmajian JV; Yucel V
    Am J Phys Med; 1974 Oct; 53(5):223-8. PubMed ID: 4153338
    [No Abstract]   [Full Text] [Related]  

  • 8. Subarachnoid phenol block in the treatment of pain and spasticity.
    Cain HD
    Paraplegia; 1965 Aug; 3(2):152-60. PubMed ID: 5898422
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin in patients with multiple sclerosis.
    Kabus C; Hecht M; Japp G; Jost WH; Pöhlau D; Stuckrad-Barre S; Winterholler M
    J Neurol; 2006 Feb; 253 Suppl 1():I26-8. PubMed ID: 16477482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guided intrathecal baclofen administration by using soleus stretch reflex in moderate-severe spastic multiple sclerosis patients with implanted pump.
    Nielsen JF; Sinkjaer T
    Mult Scler; 2004 Oct; 10(5):521-5. PubMed ID: 15471367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.
    Collin C; Davies P; Mutiboko IK; Ratcliffe S;
    Eur J Neurol; 2007 Mar; 14(3):290-6. PubMed ID: 17355549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray.
    Squintani G; Donato F; Turri M; Deotto L; Teatini F; Moretto G; Erro R
    J Neurol Sci; 2016 Nov; 370():263-268. PubMed ID: 27772772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials.
    da Rovare VP; Magalhães GPA; Jardini GDA; Beraldo ML; Gameiro MO; Agarwal A; Luvizutto GJ; Paula-Ramos L; Camargo SEA; de Oliveira LD; Bazan R; El Dib R
    Complement Ther Med; 2017 Oct; 34():170-185. PubMed ID: 28917371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin for relief of spasticity associated with multiple sclerosis.
    Dunevsky A; Perel AB
    Am J Phys Med Rehabil; 1998; 77(5):451-4. PubMed ID: 9798839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tonic spasms in multiple sclerosis. Anatomic basis and treatment.
    Honig LS; Wasserstein PH; Adornato BT
    West J Med; 1991 Jun; 154(6):723-6. PubMed ID: 1877214
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effects of intrathecal baclofen in multiple sclerosis.
    Natale M; D'Oria S; Nero VV; Squillante E; Gentile M; Rotondo M
    Clin Neurol Neurosurg; 2016 Apr; 143():121-5. PubMed ID: 26922704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper-limb spasticity during the first year after stroke: stroke arm longitudinal study at the University of Gothenburg.
    Opheim A; Danielsson A; Alt Murphy M; Persson HC; Sunnerhagen KS
    Am J Phys Med Rehabil; 2014 Oct; 93(10):884-96. PubMed ID: 25180838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of baclofen and diazepam in the treatment of spasticity.
    Cartlidge NE; Hudgson P; Weightman D
    J Neurol Sci; 1974 Sep; 23(1):17-24. PubMed ID: 4850175
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
    Gonsette RE; Capart T; Demonty L
    Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
    Kamen L; Henney HR; Runyan JD
    Curr Med Res Opin; 2008 Feb; 24(2):425-39. PubMed ID: 18167175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.